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Maternal Morbidity After Previable Prelabor 
Rupture of Membranes
Sarah K. Dotters-Katz, MD, Alexis Panzer, BA, Matthew R. Grace, MD, Marcela C. Smid, MD,
J. Adeolu Keku, BS, Catherine J. Vladutiu, PhD, Kim A. Boggess, MD, and Tracy A. Manuck, MD
OBJECTIVE: To identify risk factors for maternal morbidity
after previable prelabor rupture of membranes (PROM).
METHODS: We conducted a case–control study of sin-
gleton and twin pregnancies complicated by previable
PROM (14.0–22.9 weeks of gestation) at a single tertiary
care referral institution, 2000–2015. Pregnancies compli-
cated by fetal anomalies, previable PROM within 2
weeks of chorionic villus sampling or amniocentesis, and
those with contraindications to expectant management
(eg, chorioamnionitis) were excluded. Cases were
women with the primary outcome of composite mater-
nal morbidity (defined as having at one or more of the
following: sepsis, intensive care unit admission, acute
renal insufficiency, uterine curettage, hysterectomy, deep
vein thrombosis, pulmonary embolus, blood transfusion,
readmission, or maternal death). Controls were women
without the primary composite morbidity. Bivariate
analysis compared demographic, clinical, and manage-
ment characteristics of women in the case group and
those in the control group. Multivariable logistic regres-
sion models were developed to quantify the association
between maternal characteristics and composite severe
maternal morbidity.
RESULTS: During the study period, 174 women pre-
sented with by previable PROM and were candidates for
expectant management. Sixty-five (37%) women opted
for immediate delivery; 109 (63%) elected expectant
management. Twenty-five of 174 (14%) experienced
one or more components of the composite maternal
morbidity (cases) and were compared with 149 (86%)
women in the control group. Women in the case group
were more not more likely to elect expectant manage-
ment (68% compared with 59%, P5.40), but were more
likely to be aged 35 years or older (40% compared with
14%, P5.002) or to be carrying twins (52% compared
with 16%, P,.01). In the regression model, twin gestation
and age 35 years or older were both significantly associ-
ated with increased odds of composite maternal morbid-
ity (odds ratio [OR] 5.62, 95% confidence interval [CI]
2.21–14.3 and OR 4.00, 95% CI 1.48–10.8, respectively).
CONCLUSION: Antenatal counseling of women with
previable PROM should include that one in seven women
experience significant morbidity. Although expectant
management was not associated with increased risk in
this cohort, women with twins or those aged 35 years or
older were at substantially increased risk.
(Obstet Gynecol 2017;129:101–6)
DOI: 10.1097/AOG.0000000000001803
P relabor rupture of membranes, defined as ruptureof membranes before 37 weeks of gestation, com-
plicates 3–4% of pregnancies.1 Previable prelabor rup-
ture of membranes (PROM), defined as rupture of
membranes before 23 0/7 weeks of gestation, is less
common and occurs in only 3–4 in 1,000 pregnan-
cies.2,3 Options for women with pregnancies compli-
cated by previable PROM include immediate
delivery of a previable fetus or expectant manage-
ment with the goal of achieving fetal viability. Few
studies provide guidance for counseling women
regarding the maternal risk after previable PROM.
Published reports primarily focus on the frequency
of infectious morbidities, including chorioamnionitis
From the Division of Maternal-Fetal Medicine and the University of North
Carolina School of Medicine, University of North Carolina, Chapel Hill, North
Carolina; and the Division of Maternal-Fetal Medicine, University of Utah, Salt
Lake City, Utah.
Supported by 1UL1TR001111 from the Clinical and Translational Science
Award program of the National Center for Advancing Translational Sciences,
National Institutes of Health.
Presented as a poster at the Society for Maternal-Fetal Medicine Clinical Meeting,
February 1–6, 2016, Atlanta, Georgia.
Each author has indicated that he or she has met the journal’s requirements for
authorship.
Corresponding author: Sarah Dotters-Katz, MD, UNC Maternal-Fetal
Medicine, 3010 Old Clinic Building, CB #7516, Chapel Hill, NC 27599-
7516; email: sarahdk@med.unc.edu.
Financial Disclosure
The authors did not report any potential conflicts of interest.
(16.4–71%), endometritis (4.5–32%), and maternal
sepsis (less than 1 to 9.4%).2,4–7
There is a paucity of data regarding noninfectious
maternal morbidity, including thrombotic events, need
for blood transfusion, kidney injury, or need for
additional surgical procedures such as uterine curet-
tage or hysterectomy. Additionally, there is little
information regarding the maternal risk factors asso-
ciated with these adverse outcomes. This knowledge
limits our ability to counsel women when they present
with previable PROM but no clinical indication for
delivery. Thus, we sought to describe maternal mor-
bidities (infectious and noninfectious) and identify risk
factors for these morbidities after previable PROM.
MATERIALS AND METHODS
This is a case–control study conducted at a single
tertiary care referral center from 2000 to 2015.
Women with previable PROM between 14 0/7 weeks
and 22 6/7 weeks of gestation were identified from the
University of North Carolina–Chapel Hill Women’s
Hospital delivery log and billing records using the
International Classification of Diseases, 9th Revision
codes for previable preterm premature rupture of
membranes, premature rupture of membranes, and
spontaneous abortion (634, 635, and 637) from 2000
to 2015. All potential participants were reviewed for
eligibility by trained researchers and data were inde-
pendently verified by a second researcher; study data
were collected and managed using REDCap elec-
tronic data capture tools hosted at the University of
North Carolina.8
Women were included if rupture of membranes
occurred in the absence of labor between 14 0/7 and
22 6/7 weeks of gestation using the best available
gestational dating. Confirmation of membrane rup-
ture required medical record documentation of his-
tory, physical examination with vaginal pooling of
fluid with Nitrazine or fern testing or both positive,
low amniotic fluid volume by ultrasonography, and in
some patients, positive results from intraamniotic fluid
injection of indigo carmine. Women with labor within
24 hours of rupture, missing delivery data, uncertain
date of membrane rupture, those with major fetal
congenital anomalies, including renal anomalies asso-
ciated with oligohydramnios or anhydramnios or
membrane rupture within 48 hours of amniocentesis,
chorionic villous sampling, or fetal selective reduction
were excluded. This study was reviewed and
approved by the institutional review board at the
University of North Carolina at Chapel Hill.
Women with pregnancies complicated by pre-
viable PROM were not offered expectant management
if they had evidence of labor, chorioamnionitis, or
heavy vaginal bleeding. We classified each woman
into one of three categories: 1) those who were
candidates for expectant management and elected
termination of the pregnancy, 2) those who were
candidates for expectant management and elected
expectant management, and 3) those who presented
with a contraindication for expectant management.
Women in the third group were excluded from this
analysis.
The primary outcome was defined as a composite
of maternal morbidity, defined as at least one of the
following: infectious morbidity (maternal sepsis [by
using systemic inflammatory response syndrome
criteria]) or noninfectious morbidity (maternal inten-
sive care unit admission, acute renal insufficiency
[serum creatinine greater than 1.2], need for uterine
curettage or hysterectomy, uterine rupture, deep
vein thrombosis, pulmonary embolus, need for
blood transfusion, need for readmission, or maternal
death).9 Other morbidities examined were individual
components of the composite as well as postpartum
hemorrhage (defined as estimated blood loss greater
than 1,000 cc at delivery), endometritis, wound sero-
ma, need for postpartum antibiotics, and having
more than one complication. We also assessed a com-
posite of severe maternal morbidity as a secondary
outcome, which included hysterectomy, maternal
sepsis, pulmonary embolus, intensive care unit
admission, acute renal insufficiency (serum creati-
nine greater than 1.2), blood transfusion of two or
more units, or maternal death. Cases were defined
as women who were candidates for expectant man-
agement who developed any component of the pri-
mary composite outcome. Controls were defined as
women who candidates for expectant management
who did not develop any component of the primary
composite outcome.
For women who elected expectant management,
the decision to give antibiotics for latency was at the
discretion of the admitting health care provider and
tocolytics were not used. Demographic, antenatal, and
delivery characteristics were compared between
women in the case group and those in the control
group using x2, Fisher exact test, Student t test, or
Mann-Whitney U test as appropriate. Multivariable
logistic regression modeling was used to measure
maternal characteristics associated with maternal mor-
bidity (case status). A second model was run to assess
risk factors associated with severe maternal morbidity.
All variables that were statistically significant in the
bivariate analysis at P,.05 were included. Analyses
were performed using Stata 14.0.
RESULTS
Overall, 263 women developed previable PROM from
2000 to 2015. Of these, 37 (14%) did not meet inclusion
criteria and 52 (20%) had a contraindication for
expectant management, leaving 174 women eligible
for analysis (Fig. 1). In the study cohort, 25 (14%, 95%
confidence interval [CI] 9.5–20%) of 174 experienced
the primary outcome and were designated as cases
(Table 1). Five women (2.9%) experienced more than
one component of the maternal morbidity composite,
and 18 women (10%) experienced severe maternal
morbidity. Fifty-six women (39%) had postpartum
hemorrhage and eight (4.6%) had endometritis.
Women in the case group were significantly more
likely than women in the control group to be 35 years
of age or older (40% compared with 14%, P5.002)
and to be carrying twins (52% compared with 16%,
P,.001). Other demographic and initial clinical char-
acteristics were similar between groups (Table 2).
Multiple gestation was also more common among
women with severe maternal morbidity: 9 of 18
women (50%) compared with 27 of 156 (17%) women
without a morbidity (P5.003). Similarly, 8 of 18
women (44%) with severe morbidity but only 23 of
156 (15%) of women without a severe morbidity were
aged 35 years or older (P5.005).
Antenatal and delivery characteristics were also
similar between women in the case group and those in
the control group (Table 3). Women in the case group
were not more likely to have elected expectant man-
agement (68% compared with 59%, P5.40) nor were
women with a severe maternal morbidity more likely to
have elected expectant management (78% compared
with 58%, P5.13). The median gestational age at deliv-
ery for the first neonate (singleton or twin A) and for
twin B also did not differ between the two groups
(Table 3). Eleven women attempted an interval twin
delivery. Of these, 2 of 11 (15%) were in the case group;
this rate of maternal morbidity was similar to the over-
all cohort (25/174 [14%]). The percentage of women
who delivered after 23 weeks of gestation was similar
in both groups (32% compared with 29%, P5.80).
In the multivariable logistic regression model
including twin gestation and maternal age 35 years
or older, each was associated with increased odds of
maternal morbidity (odds ratio [OR] 5.62, 95% CI
2.21–14.3 and OR 4.00, 95% CI 1.48–10.8, respec-
tively). When considering only cases of severe mater-
nal morbidity, these two factors remained significant
(Table 4).
DISCUSSION
We found nearly one in seven women with previable
PROM who did not have contraindications to expec-
tant management experienced maternal morbidity.
Expectant management was not more common in the
Table 1. Individual Maternal Morbidities
Accounting for the 25 Cases of Composite
Morbidity*
Complication
No. of Women With
Morbidity
Sepsis 2 (1.2)
Acute renal injury 4 (2.3)
Blood transfusion 13 (7.6)
Intensive care unit admission 1 (0.6)
Hysterectomy† 2 (1.2)
Deep venous thrombosis 0








Postpartum hemorrhage 56 (39)







Data are n (%).
* Composite includes at least one of the following: maternal sepsis,
intensive care unit admission, acute renal insufficiency (serum
creatinine greater than 1.2), need for uterine curettage or
hysterectomy, deep vein thrombosis, pulmonary embolus, need
for blood transfusion, need for readmission, or maternal death.
† Both hysterectomies were for placenta accreta.
‡ Only includes those women who had uterine curettage after
vaginal delivery and cesarean delivery.
§ Severe maternal morbidity includes: hysterectomy, maternal
sepsis, pulmonary embolus, intensive care unit admission,
acute renal insufficiency (serum creatinine greater than 1.2),
blood transfusion of two or more units, or maternal death.
Fig. 1. Study population.
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women in the case group when compared with
women in the control group. However, carrying twins
compared with a singleton conferred nearly a sixfold
increased odds of maternal morbidity and those aged
35 years or older conferred a fourfold increased odds
after previable PROM. The most common maternal
morbidity in this population was blood transfusion,
occurring in 7.6% of women.
Although data to inform the discussions about
neonatal outcomes are increasingly available, there is
little information about maternal outcomes. Reddy et al
found that as gestational decreased from 33 weeks to 23
weeks, overall risk for severe maternal complications
increased. However, only half of that cohort included
women with pregnancies complicated by previable
PROM and no women with previable PROM before
23 weeks of gestation.10 In their study, if delivery
occurred between 23 and 27 weeks of gestation, the
severe maternal morbidity rate was 11.5%, consistent
with our results. Although twin gestation is thought to
be associated with an increased risk of pregnancy com-
plications and with prelabor PROM, our study also
identifies an increase in maternal risk for women with
twins complicated by previable PROM.11–13
Strengths of our study include that we examined
specific risk factors associated with maternal morbidity
and included complications with significant potential
to affect maternal health. We clearly defined case
status a priori and did not restrict the study to women
electing expectant management to better inform
counseling for women who present with previable
PROM and are faced with a decision about manage-
ment options (ie, delivery compared with expectant
management). Our population is ethnically and eco-
nomically diverse, increasing the generalizability of
our findings.
Despite these strengths, our study has limitations.
Like with all retrospective studies, we are limited by
data available in the medical record. Because we did
not have any patients with gonorrheal or chlamydial
infections in our cohort, we cannot comment on the
effect of these sexually transmitted infections as risk
factors for maternal morbidity. Furthermore, as a ter-
tiary center, our results may have been biased toward
more ill women, because those with fewer complica-
tions may have delivered at community hospitals.
Given our small sample size, we recognize our
findings may not be generalizable to the other
populations. Also, as a result of the small numbers
and retrospective nature, we were also unable to
control for factors that may play a role in maternal
outcomes, including antibiotics for latency in
this population. Current American College of
Obstetricians and Gynecologists guidelines suggest
Table 2. Demographic and Clinical Characteristics Among Women in the Case Group* and Those in the
Control Group After Previable Preterm Prelabor Rupture of Membranes, 2000–2015
Characteristic
Case Group (Women With
Composite Morbidity) (n525)
Control Group (Women Without
Composite Morbidity) (n5149) P
Maternal age (y) 33 (25–38) 29.5 (24–33) .096
Advanced maternal age (35 y or older) 10 (40) 21 (14) .002
Black race 11 (44) 71 (48) .58
Private insurance 14 (56) 68 (46) .34
Nulliparous 4 (16) 46 (31) .13
Prior preterm birth 7 (29) 34 (23) .53
Major medical comorbidity† 7 (28) 29 (19) .33
Asthma 3 (12) 17 (11) ..99
Chronic hypertension 4 (16) 13 (8.7) .27
Pregestational diabetes 0 8 (5.7) .60
Tobacco use 4 (16) 28 (19) ..99
Recreational drug use 2 (8.0) 18 (12) .74
Twin gestation 13 (52) 23 (16) ,.001
Any infection in pregnancy‡ 5 (20) 60 (40) .053
Bacterial vaginosis 2 (8.0) 14 (9.4) ..99
Urinary tract infection 3 (12) 18 (12) ..99
Human papilloma virus 2 (8.0) 30 (20) .18
Data are median (interquartile range) or n (%) unless otherwise specified.
* Women in the case groups defined as at least one of the following: maternal sepsis, intensive care unit admission, acute renal insufficiency
(serum creatinine greater than 1.2), need for uterine curettage or hysterectomy, deep vein thrombosis, pulmonary embolus, need for
blood transfusion, need for readmission, or maternal death.
† Includes chronic hypertension, diabetes, and asthma.
‡ Includes bacterial vaginosis, chlamydia, gonorrhea, urinary tract infection, and human papillomavirus.
“considering” this based on level 2C and 2B evidence
in women with previable PROM.14 Another impor-
tant limitation of this study is the sample size. Because
this was a retrospective cohort, we did not conduct an
a priori power calculation. To identify a twofold
increase in maternal morbidity associated with expec-
tant management compared with immediate delivery,
assuming an a of 0.05 and a b of 0.2, it would require
199 women in each group. Given our study size, we
have only 20% power to detect a 30% difference in
maternal morbidity among women managed expec-
tantly compared with those delivered immediately.
Thus, for women with previable PROM, we are
unable to make definitive conclusions or recommen-
dations regarding expectant management compared
with immediate delivery.
Table 3. Antenatal and Delivery Characteristics Among Women in the Case Group and Those in the
Control Group After Previable Preterm Prelabor Rupture of Membranes 2000–2015
Characteristic
Case Group (Women With
Composite Morbidity)* (n525)
Control Group (Women Without
Composite Morbidity) (n5149) P
Previable preterm PROM GA (wk) 19.1 (17.2–21.6) 20.2 (18–21.8) .45
Latency (wk)†‡ 2.0 (0.6–3.1) 2.0 (0.6–4.2) .98
Latency for twin B (wk)‡§ 2.7 (1.4–5.7) 2.0 (0.6–4.9) .60
Delivery GA (wk)† 22.1 (19–23.3) 21.3 (19.3–23.4) .83
Delivery GA for twin B (wk)§ 23.5 (23–24.2) 23.1 (20.4–23.7) .60
Latency antibioticsk 8 (38) 50 (45) .58
Expectant management 17 (68) 88 (59) .40
Clinical chorioamnionitis 5 (20) 46 (32) .23
WBC at rupture of membranes (n542) 13.5 (10.9–14.9) 11.5 (9.7–14.4) .11
WBC closest to delivery 17.9 (15.9–21.1) 14.5 (12.21–18.4) .012
Mode of delivery .94
Vaginal 17 (68) 104 (71)
Cesarean 4 (16) 20 (14)
Dilation and evacuation 4 (16) 23 (16)
EBL (cc) 800 (500–1,125) 300 (150–500) ,.001
Interval twin delivery 2 (16) 9 (39) .26
PROM, preterm prelabor rupture of membranes; GA, gestational age; WBC, white blood cell count; EBL, estimated blood loss.
Data are median (interquartile range) or n (%) unless otherwise specified.
* Women in the case group defined as at least one of the following: maternal sepsis, intensive care unit admission, acute renal insufficiency
(serum creatinine greater than 1.2), need for uterine curettage or hysterectomy, deep vein thrombosis, pulmonary embolus, need for
blood transfusion, need for readmission, or maternal death.
† For twin gestations, latency is for twin A.
‡ Latency includes only those patients who elected expectant management (17 women in the case group and 88 women in the control
group).
§ There were 17 sets of twins in the complications cohort and 19 in the no complications cohort.
k Latency antibiotics are defined as antibiotics given for the specific intention of increasing duration of pregnancy as documented in the
medical record.
Table 4. Multivariable Logistic Regression Model for Composite Maternal Morbidity and Severe Maternal
Morbidity After Previable Prelabor Rupture of Membranes From 2000 to 2015
Adjusted OR 95% CI P
Characteristics associated with maternal morbidity*
Maternal age 35 y or older 4.00 1.48–10.8 .006
Twin gestation 5.62 2.21–14.2 ,.01
Characteristics associated with severe maternal morbidity†
Maternal age 35 y or older 4.41 1.51–12.9 .007
Twin gestation 4.36 1.52–12.4 .006
OR, odds ratio; CI, confidence interval.
* Composite includes at least one of the following: maternal sepsis, intensive care unit admission, acute renal insufficiency (serum
creatinine greater than 1.2), need for uterine curettage or hysterectomy, deep vein thrombosis, pulmonary embolus, need for blood
transfusion, need for readmission, or maternal death.
† Severe maternal morbidity includes: hysterectomy, maternal sepsis, pulmonary embolus, intensive care unit admission, acute renal
insufficiency (serum creatinine greater than 1.2), blood transfusion of two or more units, or maternal death.
Maternal morbidity after previable PROM is not
rare. Approximately 14% of women who elect for
expectant management or immediate delivery after
previable PROM experience maternal morbidity.
Women with morbidity were not more likely to elect
expectant management in this cohort. However,
compared with women without morbidity, those with
morbidity were more than six times more likely to
have twins. The most common maternal complication
was blood transfusion. Clinicians may consider incor-
porating this information when counseling women
who present with previable PROM and perhaps
considering more aggressive treatment of anemia in
those women electing expectant management. Given
the rare nature of previable PROM and the limited
data on maternal and fetal risks after previable
PROM, we propose that the creation of a multicenter
prospective registry would substantially improve
knowledge about women with previable PROM.
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